Appropriate Antibiotic Use for Community-Acquired Pneumonia in Inpatient Settings and Its Impact on 30-days Readmission and Mortality Rate
Background: Community-Acquired Pneumonia (CAP) is a lower respiratory tract infection with bacteria as the most frequent causative agent. Therapy for pneumonia includes appropriate antibiotic usage. Inappropriate antibiotic use supposedly increase 30-days readmission and mortality rate. Objective:...
Saved in:
id |
id-langga.111372 |
---|---|
record_format |
dspace |
spelling |
id-langga.1113722021-10-18T00:47:08Z https://repository.unair.ac.id/111372/ Appropriate Antibiotic Use for Community-Acquired Pneumonia in Inpatient Settings and Its Impact on 30-days Readmission and Mortality Rate Rafida Sofi Kamila, - Maftuchah Rochmanti, - Arief Bachtiar, - R Medicine (General) RM Therapeutics. Pharmacology Background: Community-Acquired Pneumonia (CAP) is a lower respiratory tract infection with bacteria as the most frequent causative agent. Therapy for pneumonia includes appropriate antibiotic usage. Inappropriate antibiotic use supposedly increase 30-days readmission and mortality rate. Objective: To evaluate the antibiotic use and the impact of appropriate antibiotic use on the 30-days readmission and mortality of CAP patients in inpatient non-ICU settings. Method: A cross-sectional, analytic study was conducted. We collected data from Universitas Airlangga hospital’s medical record to obtain the details of antibiotic usage. Result were evaluated using the Gyssens algorithm. A chi-square test was used to identify the impact of appropriate antibiotic use on the 30-days readmission and mortality. Result: A total of 90 patients with CAP fulfilled the inclusion criteria. One gram of ceftriaxone IV was the most prescribed antibiotic for therapy of CAP. The amount of appropriate antibiotic use is 85.6%. Five patients (5.6%) went through the 30-days readmission. There was no death reported. The statistical test between antibiotic use and 30-days readmission obtained p value=0.894 (p>0.05). Conclusion: There was no significant impact of appropriate antibiotic use on the 30-days readmission rate and the mortality rate could not be assessed. Institute of Medico-Legal Publishers 2019-01 Article PeerReviewed text en https://repository.unair.ac.id/111372/1/Appropriate%20Antibiotic%20Use%20for%20Community-Acquired%20Pneumonia%20in%20Inpatient%20Settings%20and%20Its%20Impact%20on%2030-days%20Readmission%20and%20Mortality%20Rate.pdf text en https://repository.unair.ac.id/111372/2/Appropriate%20Antibiotic%20Use.pdf text en https://repository.unair.ac.id/111372/3/5.%20Acceptence%20Letter_Maftuchah%20with%20Rafida%20Sofi%20Kamila_IJFMT.pdf text en https://repository.unair.ac.id/111372/4/Appropriate%20Antibiotic%20Use%20for%20Community-Acquired%20Pneumonia%20in%20Inpatient%20Settings%20and%20Its%20Impact%20on%2030-days%20Readmission%20and%20Mortality%20Rate.pdf Rafida Sofi Kamila, - and Maftuchah Rochmanti, - and Arief Bachtiar, - (2019) Appropriate Antibiotic Use for Community-Acquired Pneumonia in Inpatient Settings and Its Impact on 30-days Readmission and Mortality Rate. Indian Journal of Forensic Medicine & Toxicology, 15 (1). pp. 2765-2772. ISSN 0973-9122 http://medicopublication.com/index.php/ijfmt/article/view/13817 https://doi.org/10.37506/ijfmt.v15i1.13817 |
institution |
Universitas Airlangga |
building |
Universitas Airlangga Library |
continent |
Asia |
country |
Indonesia Indonesia |
content_provider |
Universitas Airlangga Library |
collection |
UNAIR Repository |
language |
English English English English |
topic |
R Medicine (General) RM Therapeutics. Pharmacology |
spellingShingle |
R Medicine (General) RM Therapeutics. Pharmacology Rafida Sofi Kamila, - Maftuchah Rochmanti, - Arief Bachtiar, - Appropriate Antibiotic Use for Community-Acquired Pneumonia in Inpatient Settings and Its Impact on 30-days Readmission and Mortality Rate |
description |
Background: Community-Acquired Pneumonia (CAP) is a lower respiratory tract infection with bacteria
as the most frequent causative agent. Therapy for pneumonia includes appropriate antibiotic usage.
Inappropriate antibiotic use supposedly increase 30-days readmission and mortality rate. Objective: To evaluate the antibiotic use and the impact of appropriate antibiotic use on the 30-days readmission and mortality of CAP patients in inpatient non-ICU settings. Method: A cross-sectional, analytic study was conducted. We collected data from Universitas Airlangga hospital’s medical record to obtain the details of antibiotic usage. Result were evaluated using the Gyssens algorithm. A chi-square test was used to identify the impact of appropriate antibiotic use on the 30-days readmission and mortality. Result: A total of 90 patients with CAP fulfilled the inclusion criteria. One gram of ceftriaxone IV was the most prescribed antibiotic for therapy of CAP. The amount of appropriate antibiotic use is 85.6%. Five patients (5.6%) went through the 30-days readmission. There was no death reported. The statistical test between antibiotic use and 30-days readmission obtained p value=0.894 (p>0.05). Conclusion: There was no significant impact of appropriate antibiotic use on the 30-days readmission rate and the mortality rate could not be assessed. |
format |
Article PeerReviewed |
author |
Rafida Sofi Kamila, - Maftuchah Rochmanti, - Arief Bachtiar, - |
author_facet |
Rafida Sofi Kamila, - Maftuchah Rochmanti, - Arief Bachtiar, - |
author_sort |
Rafida Sofi Kamila, - |
title |
Appropriate Antibiotic Use for Community-Acquired Pneumonia in Inpatient Settings and Its Impact on 30-days Readmission and Mortality Rate |
title_short |
Appropriate Antibiotic Use for Community-Acquired Pneumonia in Inpatient Settings and Its Impact on 30-days Readmission and Mortality Rate |
title_full |
Appropriate Antibiotic Use for Community-Acquired Pneumonia in Inpatient Settings and Its Impact on 30-days Readmission and Mortality Rate |
title_fullStr |
Appropriate Antibiotic Use for Community-Acquired Pneumonia in Inpatient Settings and Its Impact on 30-days Readmission and Mortality Rate |
title_full_unstemmed |
Appropriate Antibiotic Use for Community-Acquired Pneumonia in Inpatient Settings and Its Impact on 30-days Readmission and Mortality Rate |
title_sort |
appropriate antibiotic use for community-acquired pneumonia in inpatient settings and its impact on 30-days readmission and mortality rate |
publisher |
Institute of Medico-Legal Publishers |
publishDate |
2019 |
url |
https://repository.unair.ac.id/111372/1/Appropriate%20Antibiotic%20Use%20for%20Community-Acquired%20Pneumonia%20in%20Inpatient%20Settings%20and%20Its%20Impact%20on%2030-days%20Readmission%20and%20Mortality%20Rate.pdf https://repository.unair.ac.id/111372/2/Appropriate%20Antibiotic%20Use.pdf https://repository.unair.ac.id/111372/3/5.%20Acceptence%20Letter_Maftuchah%20with%20Rafida%20Sofi%20Kamila_IJFMT.pdf https://repository.unair.ac.id/111372/4/Appropriate%20Antibiotic%20Use%20for%20Community-Acquired%20Pneumonia%20in%20Inpatient%20Settings%20and%20Its%20Impact%20on%2030-days%20Readmission%20and%20Mortality%20Rate.pdf https://repository.unair.ac.id/111372/ http://medicopublication.com/index.php/ijfmt/article/view/13817 https://doi.org/10.37506/ijfmt.v15i1.13817 |
_version_ |
1715207655456243712 |